circadian rhythm kidney transplantation
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Kidney recipients: - aged 18-85 yr - living donor transplantation - good understanding of dutch language - informed consent;Kidney donors: - aged 18-85 yr - good understanding of dutch language - informed consent
Exclusion criteria
Exclusion criteria: - use of hypnotics/melatonin during the study - relevant co-morbidity that interferes with participation in the study (e.g. heart failure NYHA class IV, instable AP, pulmonary, psychiatric, neurogic, blindness) - documented sleep apnea - alcohol / drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint: recurrence of the 'dim light melatonin onset (DLMO)' after kidney transplantation. Definition of the DLMO: melatonin concentration peak >4 pg/ml in saliva, between 7 and 12 pm. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are: changes in objective and subjective sleep parameters, changes in circadian body temperature, ambulant blood pressure profile, cardiometabolic parameters and quality of life. | — |
Countries
Netherlands